Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Fred Hutchinson Cancer Research Center
Biotech
Affini-T banks $175M to enter crowded KRAS-cancer field
Affini-T Therapeutics is hoping that $175 million in new fundraising is enough to launch two oncology programs into human trials by 2023.
Max Bayer
Mar 22, 2022 7:30am
Treating leukemia by targeting tumor 'seeds,' 'essential genes'
Mar 15, 2022 8:59am
TCR-T cells fend off evasive leukemia, solid tumors in mice
Feb 9, 2022 2:00pm
Blockbuster cancer med Keytruda may help flush out dormant HIV
Jan 26, 2022 2:00pm
Improving CAR-T with more sensitive tumor ID
Aug 25, 2021 8:15am
Sanofi pays $160M for mRNA tech to reprogram T cells in vivo
Apr 12, 2021 7:45am